A large 2014 randomised control trial has found that remote monitoring devices offer no short term benefit in health costs or outcomes for patients that monitor their health with connected devices. The trial of 160 patients with either hypertentsion, diabetes, or arrhythmia, issued them with an iPhone 4 and a device with which to monitor their condition. Commenting on the trial, study author and noted digital health advocate Dr. Eric Topol said “It was a bit disappointing, but remember, this was the first multisensor trial that’s ever been reported, so in that respect it was a pioneering effort".
A large six-month randomised control trial has found that remote monitoring devices offer no short term benefit in health costs or outcomes for patients that monitor their health with connected devices. The trial of 160 patients with either hypertentsion, diabetes, or arrhythmia, issued them with an iPhone 4 and a device with which to monitor their condition. Commenting on the trial, study author and noted digital health advocate Dr. Eric Topol said “It was a bit disappointing, but remember, this was the first multisensor trial that’s ever been reported, so in that respect it was a pioneering effort".